Nanobiotechnology and nanostructured therapeutic delivery systems

Recent Patents on Biomedical Engineering

Volumn 5, Issue 1, 2012, Pages 29-40

  Castro, Nathan ^a   Umanzor Alvarez, Jose ^a   Zhang, Lijie Grace ^a   Keidar, Michael ^a  

^a The George Washington University   (United States)

Author keywords

Cancer; Cells; Cold plasma; Drug; Nanobiotechnology; Nanomedicine; Nanoparticles; Nanostructure; Patent; Pharmaceuticals; Quantum dots; Sustained delivery; Targeted delivery; Therapeutic delivery; Tissue engineering

Indexed keywords

CANCER; COLD PLASMAS; DRUG; PATENT; SUSTAINED DELIVERY; TARGETED DELIVERY; THERAPEUTIC DELIVERY;

CELLS; DRUG DELIVERY; DRUG PRODUCTS; MEDICAL APPLICATIONS; MEDICAL NANOTECHNOLOGY; NANOPARTICLES; NANOSTRUCTURES; PATENTS AND INVENTIONS; SEMICONDUCTOR QUANTUM DOTS; TISSUE; TISSUE ENGINEERING;

NANOBIOTECHNOLOGY;

EID: 84860314148     PISSN: 18747647     EISSN: None     Source Type: Journal    
DOI: 10.2174/1874764711205010029     Document Type: Review

References (153)

1. Farokhzad OC, Langer R. Impact of Nanotechnology on Drug Delivery. Acs Nano 2009; 3: 16-20.
2. Jia L, Wong H, Cerna C, Weitman SD. Effect of nanonization on absorption of 301029: Ex vivo and in vivo pharmacokinetic correlations determined by liquid chromatography/mass spectrometry. Pharmaceut Res 2002; 19: 1091-6.
3. Anchordoquy T, Xu L. Drug Delivery Trends in Clinical Trials and Translational Medicine: Challenges and Opportunities in the Delivery of Nucleic Acid-Based Therapeutics. J Pharm Sci-Us 2011; 100: 38-52.
4. Foldvari M, Elsabahy M, Nazarali A. Non-Viral Nucleic Acid Delivery: Key Challenges and Future Directions. Curr Drug Deliv 2011; 8: 235-44.
5. Khar RK, Jain GK, Warsi MH, Mallick N, Akhter S, Pathan SA, et al. Nano-vectors for the Ocular Delivery of Nucleic Acid-based Therapeutics. Indian J Pharm Sci 2011; 72: 675-88.
6. Grund S, Bauer M, Fischer D. Polymers in Drug Delivery-State of the Art and Future Trends. Adv Eng Mater 2011; 13: B61-B87.
7. Lavik E, Kuehn MH, Kwon YH. Novel drug delivery systems for glaucoma. Eye 2011; 25: 578-86.
8. Rahman MA, Harwansh R, Mirza MA, Hussain S, Hussain A. Oral Lipid Based Drug Delivery System (LBDDS): Formulation, Characterization and Application: A Review. Curr Drug Deliv 2011; 8: 330-45.
9. Sawant KK, Petkar KC, Chavhan SS, Agatonovik-Kustrin S. Nanostructured Materials in Drug and Gene Delivery: A Review of the State of the Art. Crit Rev Ther Drug 2011; 28: 101-64.
10. Brabury J. Beyond pills and jabs. Lancet 2003; 362: 1984-5.
11. Kefalides P. New methods for drug delivery. Ann Intern Med 1998; 128: 1053-5.
12. Body JJ. Prevention and treatment of side-effects of systemic treatment: bone loss. Annals of oncology: official journal of the European Society for Medical Oncology / ESMO 2010; 21 Suppl 7: vii180-5.
13. Kvolik S, Jukic M, Matijevic M, Marjanovic K, Glavas-Obrovac L. An overview of coagulation disorders in cancer patients. Surgical oncology 2010; 19: e33-46.
14. De Jong WH, Borm PJA. Drug delivery and nanoparticles: Applications and hazards. Int J Nanomed 2008; 3: 133-49.
15. Jia XQ, Goldberg M, Langer R. Nanostructured materials for applications in drug delivery and tissue engineering. J Biomat Sci-Polym E 2007; 18: 241-68.
16. Zhang YZ, Su B, Venugopal J, Ramakrishna S, Lim CT. Biomimetic and bioactive nanofibrous scaffolds from electrospun composite nanofibers. Int J Nanomedicine 2007; 2: 623-38.
17. Zhang Y, Lim CT, Ramakrishna S, Huang ZM. Recent development of polymer nanofibers for biomedical and biotechnological applications. Journal of materials science Materials in medicine 2005; 16: 933-46.
18. Zhang X, Reagan MR, Kaplan DL. Electrospun silk biomaterial scaffolds for regenerative medicine. Advanced drug delivery reviews 2009; 61: 988-1006.
19. Wang RM, He NP, He YF, Song PF, Zhou Y, Li G. Protein Polymer Conjugates. Prog Chem 2010; 22: 2388-96.
20. Velonia K, Thordarson P, Le Droumaguet B. Well-defined proteinpolymer conjugates-synthesis and potential applications. Appl Microbiol Biot 2006; 73: 243-54.
21. Park TG, Yoo HS, Lee EA, Yoon JJ. Hyaluronic acid modified biodegradable scaffolds for cartilage tissue engineering. Biomaterials 2005; 26: 1925-33.
22. Wang YY, Lu LX, Shi JC, Wang HF, Xiao ZD, Huang NP. Introducing RGD peptides on PHBV films through PEG-containing cross-linkers to improve the biocompatibility. Biomacromolecules 2011; 12: 551-9.
23. Liu XY, Chu PK, Ding CX. Surface nano-functionalization of biomaterials. Mat Sci Eng R 2010; 70: 275-302.
24. Yoo HS, Kim TG, Park TG. Surface-functionalized electrospun nanofibers for tissue engineering and drug delivery. Advanced drug delivery reviews 2009; 61: 1033-42.
25. Prabhakaran MP, Venugopal J, Chan CK, Ramakrishna S. Surface modified electrospun nanofibrous scaffolds for nerve tissue engineering. Nanotechnology 2008; 19.
26. Tanner KE. Bioactive composites for bone tissue engineering. Proceedings of the Institution of Mechanical Engineers Part H, Journal of engineering in medicine 2010; 224: 1359-72.
27. Venkatesan J, Kim SK. Chitosan composites for bone tissue engineering--an overview. Mar Drugs 2010; 8: 2252-66.
28. Boccaccini AR, Erol M, Stark WJ, Mohn D, Hong ZK, Mano JF. Polymer/bioactive glass nanocomposites for biomedical applications: A review. Compos Sci Technol 2010; 70: 1764-76.
29. Karmakar B, Som T, Singh SP, Nath M. Nanometal-Glass Hybrid Nanocomposites: Synthesis, Properties and Applications. T Indian Ceram Soc 2010; 69: 171-86.
30. Putz G, Schmah O, Eckes J, Hug MJ, Winkler K. Controlled application and scheduled removal of nanoparticle based chemotherapeutics (CARL) will reduce dose limiting adverse events in anticancer chemotherapy. Medical hypotheses 2009; 72: 393-7.
31. Moebus K, Siepmann J, Bodmeier R. Alginate-poloxamer microparticles for controlled drug delivery to mucosal tissue. European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV 2009; 72: 42-53.
32. Campbell PG, Miller ED, Li K, Kanade T, Weiss LE, Walker LM. Spatially directed guidance of stem cell population migration by immobilized patterns of growth factors. Biomaterials 2011; 32: 2775-85.
33. Dupeyron D, Gonzalez M, Saez V, Ramon J, Rieumont J. Nanoencapsulation of protein using an enteric polymer as carrier. IEE proceedings Nanobiotechnology 2005; 152: 165-8.
34. Langer R, LaVan DA, McGuire T. Small-scale systems for in vivo drug delivery. Nat Biotechnol 2003; 21: 1184-91.
35. Moorthi C, Manavalan R, Kathiresan K. Nanotherapeutics to Overcome Conventional Cancer Chemotherapy Limitations. J Pharm Pharm Sci 2011; 14: 67-77.
36. Hollister SJ, Maddox RD, Taboas JM. Optimal design and fabrication of scaffolds to mimic tissue properties and satisfy biological constraints. Biomaterials 2002; 23: 4095-103.
37. Huang H, Yuan Q, Shah JS, Misra RD. A new family of folatedecorated and carbon nanotube-mediated drug delivery system: Synthesis and drug delivery response. Advanced drug delivery reviews 2011.
38. Tran PA, Zhang L, Webster TJ. Carbon nanofibers and carbon nanotubes in regenerative medicine. Adv Drug Deliv Rev 2009; 61: 1097-114.
39. Liu D, Liu F, Liu Z, Wang L, Zhang N. Tumor specific delivery and therapy by double-targeted nanostructured lipid carriers with anti-VEGFR-2 antibody. Molecular pharmaceutics 2011.
40. Feng SS, Mi Y, Liu YT. Formulation of Docetaxel by folic acidconjugated D-alpha-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS(2k) micelles for targeted and synergistic chemotherapy. Biomaterials 2011; 32: 4058-66.
41. Hammond PT, Poon Z, Lee JA, Huang SW, Prevost RJ. Highly stable, ligand-clustered "patchy" micelle nanocarriers for systemic tumor targeting. Nanomed-Nanotechnol 2011; 7: 201-9.
42. Leroux JC, Gaucher G, Marchessault RH. Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes. J Control Release 2010; 143: 2-12.
43. Park K, Chen HT, Kim SW, Li L, Wang SY, Cheng JX. Release of hydrophobic molecules from polymer micelles into cell membranes revealed by Forster resonance energy transfer imaging. P Natl Acad Sci USA 2008; 105: 6596-601.
44. Park K, Huh KM, Lee SC, Cho YW, Lee JW, Jeong JH. Hydrotropic polymer micelle system for delivery of paclitaxel. J Control Release 2005; 101: 59-68.
45. Park K, Kim JY, Kim S, Pinal R. Hydrotropic polymer micelles as versatile vehicles for delivery of poorly water-soluble drugs. J Control Release 2011; 152: 13-20.
46. Zhang QQ, Wang YS, Jiang Q, Li RS, Liu LL, Wang YM, et al. Self-assembled nanoparticles of cholesterol-modified Ocarboxymethyl chitosan as a novel carrier for paclitaxel. Nanotechnology 2008; 19.
47. Feng SS, Sun B. Trastuzumab-functionalized nanoparticles of biodegradable copolymers for targeted delivery of docetaxel. Nanomedicine-Uk 2009; 4: 431-45.
48. Coester C, Fuchs S. Protein-based nanoparticles as a drug delivery system: chances, risks, perspectives. J Drug Deliv Sci Tec 2010; 20: 331-42.
49. Yu L, Yang DB, Van S, Jiang XG. Novel free paclitaxel-loaded poly(L-gamma-glutamylglutamine)-paclitaxel nanoparticles. Int J Nanomed 2011; 6: 85-91.
50. Wang ZX, Wang J, Liu DJ. Synthesis and cell-surface binding of lectin-gold nanoparticle conjugates. Anal Methods-Uk 2011; 3: 1745-51.
51. Stafford RJ, Melancon MP, Lu W, Zhong M, Zhou M, Liang G, et al. Targeted multifunctional gold-based nanoshells for magnetic resonance-guided laser ablation of head and neck cancer. Biomaterials 2011; 32: 7600-8.
52. Huh YM, Yang J, Lee J, Kang J, Oh SJ, Ko HJ, et al. Smart Drug-Loaded Polymer Gold Nanoshells for Systemic and Localized Therapy of Human Epithelial Cancer. Adv Mater 2009; 21: 4339.
53. Brinker CJ, Liu JW, Jiang XM, Ashley C. Electrostatically Mediated Liposome Fusion and Lipid Exchange with a Nanoparticle-Supported Bilayer for Control of Surface Charge, Drug Containment, and Delivery. J Am Chem Soc 2009; 131: 7567.
54. Vivero-Escoto JL, Slowing II, Trewyn BG, Lin VSY. Mesoporous Silica Nanoparticles for Intracellular Controlled Drug Delivery. Small 2010; 6: 1952-67.
55. Tao X, Yang YJ, Hou QA, Ma Y, Chen XL, Chen JF. Mesoporous silica nanotubes coated with multilayered polyelectrolytes for pHcontrolled drug release. Acta Biomater 2010; 6: 3092-100.
56. Li YP, He QJ, Gao Y, Zhang LX, Zhang ZW, Gao F, et al. A pHresponsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance. Biomaterials 2011; 32: 7711-20.
57. Wang YL, Tan S, Wu QX, Wang J, Liu XL, Sui KK, et al. Dynamic self-assembly synthesis and controlled release as drug vehicles of porous hollow silica nanoparticles. Micropor Mesopor Mat 2011; 142: 601-8.
58. Veres T, Zhang XF, Clime L, Roberge H, Normandin F, Yahia L, et al. pH-Triggered Doxorubicin Delivery Based on Hollow Nanoporous Silica Nanoparticles with Free-Standing Superparamagnetic Fe(3)O(4) Cores. J Phys Chem C 2011; 115: 1436-43.
59. Ambrogio MW, Thomas CR, Zhao YL, Zink JI, Stoddart JF. Mechanized Silica Nanoparticles: A New Frontier in Theranostic Nanomedicine. Accounts of chemical research 2011.
60. Wang T, Zhang L, Su Z, Wang C, Liao Y, Fu Q. Multifunctional hollow mesoporous silica nanocages for cancer cell detection and the combined chemotherapy and photodynamic therapy. ACS applied materials & interfaces 2011; 3: 2479-86.
61. Medintz IL, Uyeda HT, Goldman ER, Mattoussi H. Quantum dot bioconjugates for imaging, labelling and sensing. Nature materials 2005; 4: 435-46.
62. Gao X, Chan WC, Nie S. Quantum-dot nanocrystals for ultrasensitive biological labeling and multicolor optical encoding. Journal of biomedical optics 2002; 7: 532-7.
63. Smith AM, Gao X, Nie S. Quantum dot nanocrystals for in vivo molecular and cellular imaging. Photochemistry and photobiology 2004; 80: 377-85.
64. Dwarakanath S, Bruno JG, Shastry A, Phillips T, John AA, Kumar A, et al. Quantum dot-antibody and aptamer conjugates shift fluorescence upon binding bacteria. Biochemical and biophysical research communications 2004; 325: 739-43.
65. Mason JN, Tomlinson ID, Rosenthal SJ, Blakely RD. Labeling cell-surface proteins via antibody quantum dot streptavidin conjugates. Methods Mol Biol 2005; 303: 35-50.
66. Chen LD, Liu J, Yu XF, Pang DW, Wang QQ, Yuan HY, et al. [Invivo targeted imaging of hepatocellular carcinoma in nude mice using quantum dot probes]. Zhonghua bing li xue za zhi Chinese journal of pathology 2007; 36: 394-9.
67. Jayagopal A, Russ PK, Haselton FR. Surface engineering of quantum dots for in vivo vascular imaging. Bioconjugate chemistry 2007; 18: 1424-33.
68. Kaul Z, Yaguchi T, Harada JI, Ikeda Y, Hirano T, Chiura HX, et al. An antibody-conjugated internalizing quantum dot suitable for long-term live imaging of cells. Biochemistry and cell biology = Biochimie et biologie cellulaire 2007; 85: 133-40.
69. Leong KW, Ho YP. Quantum dot-based theranostics. Nanoscale 2010; 2: 60-8.
70. Kostarelos K, All-Jamal WT, Al-Jamal KT, Tian B, Cakebread A, Halket JM. Tumor Targeting of Functionalized Quantum Dot-Liposome Hybrids by Intravenous Administration. Molecular pharmaceutics 2009; 6: 520-30.
71. Kostarelos K, Al-Jamal WT, Al-Jamal KT, Bomans PH, Frederik PM. Functionalized-quantum-dot-liposome hybrids as multimodal nanoparticles for cancer. Small 2008; 4: 1406-15.
72. Lim JY. Topographic Control of Cell Response to Synthetic Materials. Tissue Eng Regen Med 2009; 6: 365-70.
73. Martinez E, Lagunas A, Mills CA, Rodriguez-Segui S, Estevez M, Oberhansl S, et al. Stem cell differentiation by functionalized micro-and nanostructured surfaces. Nanomedicine 2009; 4: 65-82.
74. Ott MK, Ferraz N, Carlsson J, Hong J. Influence of nanoporesize on platelet adhesion and activation. J Mater Sci-Mater M 2008; 19: 3115-21.
75. Walboomers XF, Prodanov L, te Riet J, Lamers E, Domanski M, Luttge R, et al. The interaction between nanoscale surface features and mechanical loading and its effect on osteoblast-like cells behavior. Biomaterials 2010; 31: 7758-65.
76. Alonso MJ, D'Angelo I, Garcia-Fuentes M, Parajo Y, Welle A, Vantus T, et al. Nanoparticles Based on PLGA:Poloxamer Blends for the Delivery of Proangiogenic Growth Factors. Molecular pharmaceutics 2010; 7: 1724-33.
77. Jabbari E, Mercado AE. Effect of Encapsulation or Grafting on Release Kinetics of Recombinant Human Bone Morphogenetic Protein-2 From Self-Assembled Poly(lactide-co-glycolide ethylene oxide fumarate) Nanoparticles. Microsc Res Techniq 2010; 73: 824-33.
78. Lvov YM, Shutava TG, Balkundi SS, Vangala P, Steffan JJ, Bigelow RL, et al. Layer-by-Layer-Coated Gelatin Nanoparticles as a Vehicle for Delivery of Natural Polyphenols. Acs Nano 2009; 3: 1877-85.
79. Prakash S, Khan AA, Paul A, Abbasi S. Mitotic and antiapoptotic effects of nanoparticles coencapsulating human VEGF and human angiopoietin-1 on vascular endothelial cells. Int J Nanomed 2011; 6: 1069-81.
80. Das PK, Dutta S, Shome A, Kar T. Counterion-Induced Modulation in the Antimicrobial Activity and Biocompatibility of Amphiphilic Hydrogelators: Influence of in-Situ-Synthesized Ag-Nanoparticle on the Bactericidal Property. Langmuir 2011; 27: 5000-8.
81. Das PK, Shome A, Dutta S, Maiti S. In situ synthesized Ag nanoparticle in self-assemblies of amino acid based amphiphilic hydrogelators: development of antibacterial soft nanocomposites. Soft Matter 2011; 7: 3011-22.
82. Grant SA, Whelove OE, Cozad MJ, Lee BD, Sengupta S, Bachman SL, et al. Development and in vitro studies of a polyethylene terephthalate-gold nanoparticle scaffold for improved biocompatibility. J Biomed Mater Res B 2011; 99B: 142-9.
83. Han G, Martinez LR, Mihu MR, Friedman AJ, Friedman JM, Nosanchuk JD. Nitric Oxide Releasing Nanoparticles Are Therapeutic for Staphylococcus aureus Abscesses in a Murine Model of Infection. Plos One 2009; 4.
84. Krishnan LK, Madhavan RV, Rosemary MJ, Nandkumar MA, Krishnan KV. Silver Nanoparticle Impregnated Poly (epsilon-Caprolactone) Scaffolds: Optimization of Antimicrobial and Noncytotoxic Concentrations. Tissue Eng Pt A 2011; 17: 439-49.
85. Guo J, Zhang X, Li Q, Li W. Biodistribution of functionalized multiwall carbon nanotubes in mice. Nuclear medicine and biology 2007; 34: 579-83.
86. Jain AK, Dubey V, Mehra NK, Lodhi N, Nahar M, Mishra DK, et al. Carbohydrate-conjugated multiwalled carbon nanotubes: development and characterization. Nanomedicine-Uk 2009; 5: 432-42.
87. Saito N, Usui Y, Aoki K, Narita N, Shimizu M, Ogiwara N, et al. Carbon nanotubes for biomaterials in contact with bone. Current medicinal chemistry 2008; 15: 523-7.
88. Zanello LP, Zhao B, Hu H, Haddon RC. Bone cell proliferation on carbon nanotubes. Nano letters 2006; 6: 562-7.
89. Zhao Q, Yin J, Feng X, Shi Z, Ge Z, Jin Z. A biocompatible chitosan composite containing phosphotungstic acid modified single-walled carbon nanotubes. J Nanosci Nanotechnol 2010; 10: 7126-9.
90. Bekyarova E, Ni Y, Malarkey EB, Montana V, McWilliams JL, Haddon RC, et al. Applications of Carbon Nanotubes in Biotechnology and Biomedicine. Journal of biomedical nanotechnology 2005; 1: 3-17.
91. Lee HH, Sang Shin U, Lee JH, Kim HW. Biomedical nanocomposites of poly(lactic acid) and calcium phosphate hybridized with modified carbon nanotubes for hard tissue implants. Journal of biomedical materials research Part B, Applied biomaterials 2011; 98B: 246-54.
92. Liao H, Paratala B, Sitharaman B, Wang Y. Applications of carbon nanotubes in biomedical studies. Methods Mol Biol 2011; 726: 223-41.
93. Liu B, Zhang ZQ, Chen YL, Jiang H, Hwang KC, Huang Y. Mechanical properties of functionalized carbon nanotubes. Nanotechnology 2008; 19.
94. Olakowska E, Woszczycka-Korczynska I, Jedrzejowska-Szypulka H, Lewin-Kowalik J. Application of nanotubes and nanofibres in nerve repair. A review. Folia Neuropathol 2010; 48: 231-7.
95. Sahithi K, Swetha M, Ramasamy K, Srinivasan N, Selvamurugan N. Polymeric composites containing carbon nanotubes for bone tissue engineering. Int J Biol Macromol 2010; 46: 281-3.
96. Hughes GA. Nanostructure-mediated drug delivery. Nanomedicine-Uk 2005; 1: 22-30.
97. Bianco A, Kostarelos K, Partidos CD, Prato M. Biomedical applications of functionalised carbon nanotubes. Chem Commun (Camb) 2005: 571-7.
98. Prato M, Bianco A, Kostarelos K. Applications of carbon nanotubes in drug delivery. Curr Opin Chem Biol 2005; 9: 674-9.
99. Zhang L, Chen Y, Rodriguez J, Fenniri H, Webster TJ. Biomimetic helical rosette nanotubes and nanocrystalline hydroxyapatite coatings on titanium for improving orthopedic implants. Int J Nanomedicine 2008; 3: 323-33.
100. Zhang L, Hemraz UD, Fenniri H, Webster TJ. Tuning cell adhesion on titanium with osteogenic rosette nanotubes. Journal of biomedical materials research Part A 2010; 95: 550-63.
101. Zhang L, Rakotondradany F, Myles AJ, Fenniri H, Webster TJ. Arginine-glycine-aspartic acid modified rosette nanotube-hydrogel composites for bone tissue engineering. Biomaterials 2009; 30: 1309-20.
102. Zhang L, Ramsaywack S, Fenniri H, Webster TJ. Enhanced osteoblast adhesion on self-assembled nanostructured hydrogel scaffolds. Tissue Eng Part A 2008; 14: 1353-64.
103. Zhang L, Rodriguez J, Raez J, Myles AJ, Fenniri H, Webster TJ. Biologically inspired rosette nanotubes and nanocrystalline hydroxyapatite hydrogel nanocomposites as improved bone substitutes. Nanotechnology 2009; 20: 175101.
104. Boudriot U, Dersch R, Greiner A, Wendorff JH. Electrospinning approaches toward scaffold engineering--a brief overview. Artificial organs 2006; 30: 785-92.
105. Dahlin RL, Kasper FK, Mikos AG. Polymeric nanofibers in tissue engineering. Tissue engineering Part B, Reviews 2011; 17: 349-64.
106. Kumbar SG, James R, Nukavarapu SP, Laurencin CT. Electrospun nanofiber scaffolds: engineering soft tissues. Biomed Mater 2008; 3: 034002.
107. Liao S, Li B, Ma Z, Wei H, Chan C, Ramakrishna S. Biomimetic electrospun nanofibers for tissue regeneration. Biomed Mater 2006; 1: R45-53.
108. Yang X, Yang F, Walboomers XF, Bian Z, Fan M, Jansen JA. The performance of dental pulp stem cells on nanofibrous PCL/gelatin/ nHA scaffolds. Journal of biomedical materials research Part A 2010; 93: 247-57.
109. Wang J, Liu X, Jin X, Ma H, Hu J, Ni L, et al. The odontogenic differentiation of human dental pulp stem cells on nanofibrous poly(L-lactic acid) scaffolds in vitro and in vivo. Acta Biomater 2010; 6: 3856-63.
110. Thomas V, Dean DR, Jose MV, Mathew B, Chowdhury S, Vohra YK. Nanostructured biocomposite scaffolds based on collagen coelectrospun with nanohydroxyapatite. Biomacromolecules 2007; 8: 631-7.
111. Sheikh FA, Barakat NA, Kanjwal MA, Nirmala R, Lee JH, Kim H, et al. Electrospun titanium dioxide nanofibers containing hydroxyapatite and silver nanoparticles as future implant materials. Journal of materials science Materials in medicine 2010; 21: 2551-9.
112. Piskin E, Isoglu IA, Bolgen N, Vargel I, Griffiths S, Cavusoglu T, et al. In vivo performance of simvastatin-loaded electrospun spiralwound polycaprolactone scaffolds in reconstruction of cranial bone defects in the rat model. Journal of biomedical materials research Part A 2009; 90: 1137-51.
113. Linh NT, Lee BT. Electrospinning of polyvinyl alcohol/gelatin nanofiber composites and cross-linking for bone tissue engineering application. Journal of biomaterials applications 2011.
114. Yuan XY, Cao WX, Zhang H. Ultrafine Fibrous Membranes by Coaxial Electrospinning for Artificial Blood Vessel. Chem J Chinese U 2011; 32: 1396-400.
115. Xu CY, Inai R, Kotaki M, Ramakrishna S. Electrospun nanofiber fabrication as synthetic extracellular matrix and its potential for vascular tissue engineering. Tissue Eng 2004; 10: 1160-8.
116. Kim SH, Park IS, Kim SH, Kim YH, Kim IH. A Collagen/Smooth Muscle Cell-Incorporated Elastic Scaffold for Tissue-Engineered Vascular Grafts. J Biomat Sci-Polym E 2009; 20: 1645-60.
117. He W, Ma ZW, Teo WE, Dong YX, Robless PA, Lim TC, et al. Tubular nanofiber scaffolds for tissue engineered small-diameter vascular grafts. Journal of biomedical materials research Part A 2009; 90A: 205-16.
118. Fan JT, Wu HJ, Chu CC, Wu J. Electrospinning of small diameter 3-D nanofibrous tubular scaffolds with controllable nanofiber orientations for vascular grafts. J Mater Sci-Mater M 2010; 21: 3207-15.
119. Choi WS, Bae JW, Lim HR, Joung YK, Park JC, Kwon IK, et al. RGD peptide-immobilized electrospun matrix of polyurethane for enhanced endothelial cell affinity. Biomedical Materials 2008; 3.
120. Kong M, Keidar M, Ostrikov K. Plasmas meet nanoparticles-where synergies can advance the frontier of medicine. J Phys D: Appl Phys 2011 44: 174018.
121. Sengupta S, Sasisekharan R. Exploiting nanotechnology to target cancer. Br J Cancer 2007; 96: 1315-9.
122. Mukherjee P, Bhattacharya R, Wang P, Wang L, Basu S, Nagy JA, et al. Antiangiogenic properties of gold nanoparticles. Clin Cancer Res 2005; 11: 3530-4.
123. Khan MK, Minc LD, Nigavekar SS, Kariapper MS, Nair BM, Schipper M, et al. Fabrication of {198Au0} radioactive composite nanodevices and their use for nanobrachytherapy. Nanomedicine 2008; 4: 57-69.
124. Chanda N, Kan P, Watkinson LD, Shukla R, Zambre A, Carmack TL, et al. Radioactive gold nanoparticles in cancer therapy: therapeutic efficacy studies of GA-198AuNP nanoconstruct in prostate tumor-bearing mice. Nanomedicine 2010; 6: 201-9.
125. Han ZJ, Levchenko I, Kumar S, Yajadda MMA, Yick S, Seo DH, et al. Plasma nanofabrication and nanomaterials safety. J Phys D: Appl Phys 2011; 44: 174019.
126. Keidar M, Walk R, Shashurin A, Srinivasan P, Sandler A, Dasgupta S, et al. Cold plasma selectivity and the possibility of a paradigm shift in cancer therapy. Br J Cancer 2011; 105: 1295-301.
127. Keidar M, Beilis II, Boxman RL, Goldsmith S. Non-stationary macroparticle charging in an arc plasma jet. IEEETrans Plasma Sci 1995; 23: 902-8.
128. Kim GC, Kim GJ, Park SR, Jeon SM, Seo HJ, Iza F, et al. Air plasma coupled with antibody-conjugated nanoparticles: a new weapon against cancer J Phys D: Appl Phys 2009; 42: 032005.
129. Bawa R, Bawa SR, Maebius SB, Flynn T, Wei C. Protecting new ideas and inventions in nanomedicine with patents. Nanomedicine-Uk 2005; 1: 150-8.
130. Chen H, Roco MC, Li X, Lin Y. Trends in nanotechnology patents. Nat Nano 2008; 3: 123-5.
131. Bawa R. Will the nanomedicine "patent land grab" thwart commercialization? Nanomedicine-Uk 2005; 1: 346-50.
132. Jain KK. Advances in the field of nanooncology. BMC Med 2010; 8: 83.
133. Yallapu MM, Jaggi M, Chauhan SC. Scope of nanotechnology in ovarian cancer therapeutics. J Ovarian Res 2010; 3: 19.
134. Salata O. Applications of nanoparticles in biology and medicine. J Nanobiotechnology 2004; 2: 3.
135. Zhang L, Webster TJ. Nanotechnology and Nanomaterials: Promises for Improved Tissue Regeneration. Nanotoday 2009; 4: 66-80.
136. Kairdolf BA, Nie S. Coated quantum dots and methods of making and using thereof. US20110189102, 2011.
137. Lele TP, Ren F, Keselowsky BG, Lee J, Gupte A, Chu B, et al. Nanorod materials and methods of making and using same. US20110091510, 2011.
138. Fischer KC, General S. Functionalized solid polymer nanoparticles for diagnostic and therapeutic applications. US20100196280, 2010.
139. Branham KD, Brostin J, Kaminski JA. Nanofibers having embedded particles. US20100144228, 2010.
140. Razavi A. Nanodiamond enhanced drugs. US20100129457, 2010.
141. Tan J, Yoo YL. Calcium phosphate nanofibers. US20090317446, 2009.
142. Li N, Tan W. Intellligent nanomedicine integrating diagnosis and therapy. US20090202507, 2009.
143. Punnoose A, Madhusudan KR, Wingett D. Preferential killing of cancer cells and activated human T cells using ZnO nanoparticles. US20090136580, 2009.
144. Cohn D, Lando G. Polymeric nano-shells. US20090074819, 2009.
145. Boyes SG, Rowe MD, Hotchkiss J. Gold nanoparticle conjugates and uses thereof. US20090060839, 2009.
146. Cheng J, Tong R. Particulate drug delivery. US20080248126, 2008.
147. Mohapatra SS, Kumar A. Method of drug delivery by carbon nanotube-chitosan nanocomplexes. US20080214494, 2008.
148. Leary JF, Prow TW. Molecular programming of nanoparticle systems for an ordered and controlled sequence of events for genedrug delivery. US20070190155, 2007.
149. Webster TJ, Ejiofor J. Metallic nanoparticles as orthopedic biomaterial. US7824462, 2010.
150. Haberstroh KM, Webster TJ, Thapa A, Miller D. Nano-structured polymers for use as implants. US7622129, 2009.
151. Webster TJ, Siegel RW, Bizios R. Nanostructured ceramics and composite materials for orthopaedic-dental implants. US6270347, 2001.
152. Park GE, Ward BC, Park K, Webster TJ. PLGA substrate with aligned and nano-sized surface structures and associated method. US7527803, 2010.
153. Webster TJ, McKenzie J. Nanofibers as a neural biomaterial. US7993412, 2011.